Ardx News - (nasdaq:ardx) q4 2023 earnings call transcript february 22, 2024 ardelyx, inc. Web the fda approved ardelyx inc's (nasdaq:ardx) xphozah (tenapanor), the first and only phosphate absorption. Web ardelyx receives complete response letter from u.s. Fda for new drug application for tenapanor for the control. Thu, feb 22, 2024, 4:45 pm 4 min read.
Web the fda approved ardelyx inc's (nasdaq:ardx) xphozah (tenapanor), the first and only phosphate absorption. (nasdaq:ardx) q4 2023 earnings call transcript february 22, 2024 ardelyx, inc. Web ardelyx receives complete response letter from u.s. Fda for new drug application for tenapanor for the control. Thu, feb 22, 2024, 4:45 pm 4 min read.